BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24190459)

  • 21. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients.
    Kaduthanam S; Gade S; Meister M; Brase JC; Johannes M; Dienemann H; Warth A; Schnabel PA; Herth FJ; Sültmann H; Muley T; Kuner R
    Lung Cancer; 2013 May; 80(2):223-7. PubMed ID: 23410826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Factors for the Preoperative Prediction of Tumour Subtype and Prognosis in Patients with T1 Lung Adenocarcinoma.
    Zhu WY; Zhang YK; Chai ZD; Hu XF; Tan LL; Wang ZY; Chen ZJ; Le HB
    Dis Markers; 2016; 2016():9354680. PubMed ID: 28115792
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
    Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
    Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between pre-treatment serum carcinoembryonic antigen levels and genotypes in a large population of Chinese people with advanced lung adenocarcinoma.
    Liu J; Zhao YQ; Han X; Hu XF; Wu HB; Chen LJ; Song YP
    Intern Med J; 2019 May; 49(5):634-643. PubMed ID: 30379408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
    Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
    Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
    Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
    Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
    Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
    Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
    Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis value of serum NKX2-1 for primary lung cancer].
    Yang L; Ruan WJ; Chen EG; Ying KJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):535-9. PubMed ID: 23086646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
    Yang Q; Zhang P; Wu R; Lu K; Zhou H
    Dis Markers; 2018; 2018():2082840. PubMed ID: 30364165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer.
    Sun M; Song J; Zhou Z; Zhu R; Jin H; Ji Y; Lu Q; Ju H
    Dis Markers; 2016; 2016():3823121. PubMed ID: 26880855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
    Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
    Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.
    Deng T; Yuan Y; Zhang C; Zhang C; Yao W; Wang C; Liu R; Ba Y
    Cell Physiol Biochem; 2016; 39(5):1716-1722. PubMed ID: 27639768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.